Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

OBJECTIVE: To study the effect of methotrexate (MTX) and its discontinuation on the humoral immune response after COVID-19 vaccination in patients with autoimmune rheumatic diseases (AIRD). METHODS: In this retrospective study, neutralising SARS-CoV-2 antibodies were measured after second vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Arumahandi de Silva, Amanthi Nadira, Frommert, Leonie Maria, Albach, Fredrik N, Klotsche, Jens, Scholz, Veronika, Jeworowski, Lara Maria, Schwarz, Tatjana, ten Hagen, Alexander, Zernicke, Jan, Corman, Victor Max, Drosten, Christian, Burmester, Gerd-Rüdiger, Biesen, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120396/
https://www.ncbi.nlm.nih.gov/pubmed/35288376
http://dx.doi.org/10.1136/annrheumdis-2021-221876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120396/
https://www.ncbi.nlm.nih.gov/pubmed/35288376
http://dx.doi.org/10.1136/annrheumdis-2021-221876

Ejemplares similares